In a recent S&R Research publish Global 70 kDa Ribosomal Protein S6 Kinase Market Insights, Forecast to 2025, analysts provide an in-depth analysis of the global market for 70 kDa Ribosomal Protein S6 Kinase. By analyzing its historical and forecast data, the analysis analyzes the different aspects of the market. Some are part of the coverage and are the core and emerging players being profiled ArQule, Inc., Astex Pharmaceuticals Inc, Eddingpharm, Merck KGaA, PharmAust Limited, Phoenix Biotechnology, Inc., Sentinel Oncology Limited
- Forums
- ASX - By Stock
- PAA
- Certainty , What We Do Know
Certainty , What We Do Know, page-17
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $82.65M |
Open | High | Low | Value | Volume |
17.0¢ | 18.0¢ | 17.0¢ | $32.57K | 186.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 126411 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 253154 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 125011 | 0.170 |
12 | 223341 | 0.165 |
8 | 332077 | 0.160 |
4 | 512800 | 0.155 |
10 | 378999 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 236237 | 5 |
0.185 | 264496 | 4 |
0.190 | 268528 | 5 |
0.195 | 182632 | 4 |
0.200 | 1144778 | 15 |
Last trade - 11.48am 15/08/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online